🇺🇸 FDA
Patent

US 11142750

Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome

granted A61KA61K47/6929A61K9/1617

Quick answer

US patent 11142750 (Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome) held by Precision BioSciences, Inc. expires Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Precision BioSciences, Inc.
Grant date
Tue Oct 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K47/6929, A61K9/1617